Trial Profile
Clinical Trials Insight: 700040214
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 31 Dec 2008
Price :
$35
*
At a glance
- Drugs LU AA 38466 (Primary)
- Indications Neurological disorders
- Focus Adverse reactions
- Sponsors Lundbeck A/S
- 31 Dec 2008 New trial record.